The timing of azithromycin treatment is not associated with the clinical prognosis of childhood Mycoplasma pneumoniae pneumonia in high macrolide-resistant prevalence settings.

Dehua YangLinghong ChenZhimin Chen

Published in: PloS one (2018)

The timing of azithromycin treatment is not associated with the clinical prognosis of Mycoplasma pneumoniae pneumonia in children in high macrolide-resistant Mycoplasma pneumoniae prevalence settings.

Keyphrases

respiratory tract
risk factors
young adults
intensive care unit
combination therapy
replacement therapy
acute respiratory distress syndrome